Outcomes, preferences for resuscitation, and physician-patient communication among patients with metastatic colorectal cancer

American Journal of Medicine

Volumn 105, Issue 3, 1998, Pages 222-229

  Haidet, Paul ^a   Hamel, Mary Beth ^a   Davis, Roger B ^a   Wenger, Neil ^b   Reding, Douglas ^e   Kussin, Peter S ^f   Connors Jr , Alfred F ^d   Lynn, Joanne ^c   Weeks, Jane C ^g   Phillips, Russell S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e MARSHFIELD CLINIC   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; COLORECTAL CANCER; DOCTOR PATIENT RELATION; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; QUALITY OF LIFE; RESUSCITATION; TERMINAL CARE;

CARDIOPULMONARY RESUSCITATION; COLORECTAL NEOPLASMS; COMMUNICATION; FEMALE; HUMANS; MALE; PHYSICIAN-PATIENT RELATIONS; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0032169003     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00242-3     Document Type: Article

References (54)

1. 1. Parker SL, Tong L, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin. 1996;46:5-27.
2. 2. Toribara NW, Sleisenger MH. Screening for colorectal cancer. NEJM. 1995;332:861-867.
3. 3. Ferrante JM. Colorectal cancer screening. Med Clin North Am. 1996;80:27-43.
4. 4. Steele G Jr. Accomplishment and promise in the understanding and treatment of colorectal cancer. Lancet. 1993;342:1092-1096.
5. 5. Sprangers MA, Taal BG, Aaronson NK, te Velde A. Quality of life in colorectal cancer stoma vs nonstoma patients. Dis Colon Rectum. 1995;38:361-369.
6. 6. van Triest B, van Groeningen CJ, Pinedo HM. Current chemotherapeutic possibilities in the treatment of colorectal cancer. Eur J Cancer. 1995;31A(7-8):1193-1197.
7. 7. Meropol NJ, Creaven PJ, Petrelli NJ. Metastatic colorectal cancer: advances in biochemical modulation and new drug development. Semin Oncol. 1995;22:509-524.
8. 8. Kemeny N. Current approaches to metastatic colorectal cancer. Semin Oncol. 1994;21(suppl)7:67-75.
9. 9. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. NEJM. 1993;326:653-657.
10. 10. Wade TP, Virgo KS, Li MJ, et al. Outcomes after detection of metastatic carcinoma of the colon and rectum in a national hospital system. J Am Coll Surg. 1996;182:353-361.
11. 11. Saenz NC, Cady B, McDremott WV Jr, Steele GD Jr. Experience with colorectal carcinoma metastatic to the liver. Surg Clin North Am. 1989;69:361-370.
12. 12. Patanaphan V, Salazar OM. Colorectal cancer: metastatic patterns and prognosis. South Med J. 1993;86:38-41.
13. 13. Zalcberg JR, Friedlander ML, Collopy BT, et al. Treatment principles in advanced colorectal cancer. Aust N Z J Surg. 1996;66:202-205.
14. 14. The SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients; the study to understand prognoses and preferences for outcomes and risks of treatments. JAMA. 1995;274(20);1591-1598.
15. 15. Bedell SE, Delbanco TL. Choices about cardiopulmonary resuscitation in the hospital. When do physicians talk with patients? NEJM. 1984;310:1089-1093.
16. 16. Uhlmann RF, Pearlman RA, Cain KC. Physicians' and spouses' predictions of elderly patients' resuscitation preferences. J Gerontol. 1988;43:M115-M121.
17. 17. Uhlmann RF, Pearlman RA, Cain KC. Understanding of elderly patients' resuscitation preferences by physicians and nurses. West J Med. 1989;150:705-707.
18. 18. Reilly BM, Magnussen CR, Ross J, et al. Can we talk? Inpatient discussions about advance directives in a community hospital; attending physicians' attitudes, their inpatients' wishes, and reported experience. Arch Intern Med. 1994;154:2299-2308.
19. 19. Murphy DJ, Burrows D, Santilli S, et al. The influence of the probability of survival on patients' preferences regarding cardiopulmonary resuscitation. NEJM. 1994;330:545-549.
20. 20. Murphy DJ, Cluff LE. SUPPORT: study to understand prognoses and preferences for outcomes and risks of treatments. Study design. J Clin Epidemiol. 1990;43(suppl).
21. 21. Murphy DJ, Knaus WA, Lynn J. Study population in SUPPORT: patients (as defined by disease categories and mortality projections), surrogates, and physicians. J Clin Epidemiol. 1990;43(suppl): 11S-28S.
22. 22. Kreling B, Robinson DK, Bergner M. Data collection strategies in SUPPORT. J Clin Epidemiol. 1990;43(suppl):5S-10S.
23. 23. Phillips RS, Murphy DJ, Goldman L, Knaus WA. Patient characteristics in SUPPORT: disease specific clinical data. J Clin Epidemiol. 1990;43(suppl):41S-46S.
24. 24. Phillips RS, Knaus WA. Patient characteristics in SUPPORT: sociodemographics, admission diagnosis, co-morbidities and acute physiology score. J Clin Epidemiol. 1990;43(suppl):29S-32S.
25. 25. Phillips RS, Goldman L, Bergner M. Patient characteristics in SUPPORT: activity status and cognitive function. J Clin Epidemiol. 1990;43(suppl):33S-36S.
26. 26. Landefeld CS, Phillips RS, Bergner M. Patient characteristics in SUPPORT: functional status. J Clin Epidemiol. 1990;43(suppl)37S-40S.
27. 27. Coulton CJ. Decision making in SUPPORT: patient perceptions and preferences. J Clin Epidemiol. 1990;43(suppl):51S-54S.
28. 28. Phillips RS, Wenger NS, Teno J, et al. Choices of seriously ill patients about cardiopulmonary resuscitation: correlates and outcomes. Am J Med. 1996;100:128-137.
29. 29. Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function. JAMA. 1963;185:914-919.
30. 30. Borsson B, Asberg KH. Katz index of independence in ADL: reliability and validity in short term care. Scand J Rehabil Med. 1984; 16:125-132.
31. 31. Katz S, Apkom CA. A measure of primary sociobiological functions. Int J Health Serv. 1976;6:493-507.
32. 32. Tsevat J, Dawson NV, Matchar DB. Assessing quality of life and preferences in the seriously ill using utility theory. J Clin Epidemiol. 1990;43(suppl):73S-78S.
33. 33. McNair DM, Lorr M, Droppleman LF. EITS Manual For the Profile of Mood States. San Diego: Educational and Industrial Testing Service; 1971.
34. 34. Shacham S. A shortened version of the Profile of Mood States. J Pers Assess. 1983;47:305-306.
35. 35. Cella DF, Tross S, Orav EJ, et al. Mood states of patients after the diagnosis of cancer. J Psychosocial Oncol. 1989;7:45-53.
36. 36. Connors AF Jr, Dawson NV, Arkes HR, Roach MJ. Decision making in SUPPORT: physician perceptions and preferences. J Clin Epidemiol. 1990;43(suppl):59S-62S.
37. 37. Knaus WA, Harrell FE Jr, Lynn J, et al. The SUPPORT prognostic model. objective estimates of survival for seriously ill hospitalized adults. Study to understand prognoses and preferences for outcomes and risks of treatments. Ann Intern Med. 1995;122: 191-203.
38. 38. Oye RK, Landefeld CS, Jayes RL. Outcomes in SUPPORT. J Clin Epidemiol. 1990;43(suppl): 83S-88S.
39. 39. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc. 1958;53:457-481.
40. 40. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143: 29-36.
41. 41. Weinstein ND. Unrealistic optimism about susceptibility to health problems: conclusions from a community-wide sample. J Behav Med. 1987;10:481-500.
42. 42. Weinstein ND. The precaution adoption process. Health Psychol. 1988;7:355-386.
43. 43. Weinstein ND, Klotz ML, Sandman PM. Optimistic biases in public perceptions of the risk from radon. Am J Public Health. 1988;78: 796-800.
44. 44. O'Day SJ, Weeks JC, Cook EF, et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. Clin Res. 1993;41:579A.
45. 45. Weeks JC, Cook EF, O'Day SJ, et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA. 1998;279:1709-1714.
46. 46. Johnston SC, Pfeifer MP, McNutt R. The discussion about advance directives. patient and physician opinions regarding when and how it should be conducted. End of life study group. Arch Intern Med. 1995;155:1025-1030.
47. 47. Allen-Mersh TG, Earlam S, Fordy C, et al. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet. 1994;344:1255-1260.
48. 48. Padilla GV, Grant MM, Lipsett J, et al. Health quality of life and colorectal cancer. Cancer. 1992;70(suppl 5):1450-1456.
49. 49. Glimelius B, Hoffman K, Graf W, et al. Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. The nordic gastrointestinal tumor adjuvant therapy group. Cancer. 1994;73:556-562.
50. 50. Poon MA, O'Connell MJ, Moertel CG, et al. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol. 1989;7:1407-1418.
51. 51. Glimelius B, Graf W, Hoffmann K, et al. General condition of asymptomatic patients with advanced colorectal cancer receiving palliative chemotherapy. A longitudinal study. Acta Oncol. 1992;31: 645-651.
52. 52. Hakim RB, Teno JM, Harrell FE, et al. Factors associated with do-not-resuscitate orders: patients' preferences, prognoses, and physicians' judgements. Ann Intern Med. 1996;25:284-293.
53. 53. Layde PM, Beam CA, Broste SK, et al. Surrogates predictions of seriously ill patients' resuscitation preferences. Arch Fam Med. 1995;4:518-523.
54. 54. Rosenfeld KE, Wenger NS, Phillips RS, et al. Factors associated with change in resuscitation preference of seriously ill patients. Arch Intern Med. 1996:156:1558-1564.